Literature DB >> 8111567

Outcome of wheeze in childhood. Symptoms and pulmonary function 25 years later.

D J Godden1, S Ross, M Abdalla, D McMurray, A Douglas, D Oldman, J A Friend, J S Legge, J G Douglas.   

Abstract

The outcome after 25 yr was studied for three groups of children classified in a random community survey in 1964 as having asthma (121 subjects), wheeze in the presence of infection (167 subjects), or no respiratory symptoms (167 comparison subjects). Approximately 80% of the subjects in each group, now aged 34 to 40 yr, were successfully traced. Current symptoms and smoking habit were recorded by questionnaire, and ventilatory function, peak flow variability, and bronchial reactivity to inhaled methacholine were measured. Subjects who had asthma in childhood were more likely to wheeze (odds ratio [OR] 14.4) or produce phlegm (OR 3.3) than comparison subjects. They also had significantly lower FEV1 values and greater bronchial reactivity than comparison subjects. Adult FEV1 correlated with childhood FEV1 (both expressed as % of predicted) (r = 0.44, p < 0.01). The prognosis for those children who were classed as having wheeze in the presence of infection in 1964 was better than for those who had asthma. Although they also were more likely to report wheeze (OR 3.8) or phlegm (OR 4.4) than comparison subjects, the wheezy symptoms were unlikely to interfere with activities and the ventilatory function and bronchial reactivity to methacholine did not differ from those of comparison subjects. Smokers were more likely to report wheeze (OR 2.0), cough (OR 7.2), and phlegm (OR 3.1) than never-smokers, and current smokers with current wheezy symptoms had significantly reduced FEV1 values, although smoking was not associated with increased methacholine reactivity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8111567     DOI: 10.1164/ajrccm.149.1.8111567

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

1.  Association of CCR5Delta32 with reduced risk of childhood but not adult asthma.

Authors:  P Srivastava; P J Helms; D Stewart; M Main; G Russell
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

2.  Relationship between birth weight and adult lung function: controlling for maternal factors.

Authors:  C A Edwards; L M Osman; D J Godden; D M Campbell; J G Douglas
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

3.  Childhood factors associated with asthma remission after 30 year follow up.

Authors:  J M Vonk; D S Postma; H M Boezen; M H Grol; J P Schouten; G H Koëter; J Gerritsen
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

Review 4.  Prognostic factors for the outcome of childhood asthma in adolescence.

Authors:  R J Roorda
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 5.  Epidemiology of asthma and recurrent wheeze in childhood.

Authors:  Anne L Wright
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

Review 6.  Asthma: epidemiology, etiology and risk factors.

Authors:  Padmaja Subbarao; Piush J Mandhane; Malcolm R Sears
Journal:  CMAJ       Date:  2009-09-14       Impact factor: 8.262

7.  Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex.

Authors:  A Dijkstra; J M Vonk; H Jongepier; G H Koppelman; J P Schouten; N H T ten Hacken; W Timens; D S Postma
Journal:  Thorax       Date:  2005-11-24       Impact factor: 9.139

8.  Incidence and prognosis of asthma to age 33. Asthma or wheezy bronchitis in childhood is independent risk factor for wheezing symptoms in adulthood.

Authors:  S Ross; D Godden; J Friend; J Legge; G Douglas
Journal:  BMJ       Date:  1996-09-28

Review 9.  Strategies to alter the natural history of childhood asthma.

Authors:  K A Lee-Sarwar; L B Bacharier; A A Litonjua
Journal:  Curr Opin Allergy Clin Immunol       Date:  2017-04

10.  Childhood exposure to infection and risk of adult onset wheeze and atopy.

Authors:  C Bodner; W J Anderson; T S Reid; D J Godden
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.